Agilent Technologies (A) Corporate presentation summary

Applied market opportunity

• Portfolio spans Chemicals & Advanced Materials ($9B TAM), Environmental & Forensics ($7B), and Food ($6B), based on 2025 estimates.

• Market niches include semiconductors, energy & batteries, PFAS and microplastics, aviation security, drug testing, regulatory testing, emerging contaminants, packaging, and food quality & flavor.

• Pharma & biotech and clinical & diagnostics offerings include digital platforms connecting workflows from sample to insight.

GC innovation and productivity

• Five decades of GC innovation progressed from Intuvo 9000 in 2016 to 8890/8860 in 2019, 8850 in 2024, and 8890B/8860B in 2026.

• 8890B and 8860B deliver 30% faster cooldown for higher sample throughput, with lower gas and power use and proactive maintenance to prevent downtime.

• Built-in GC Assist monitors, tracks, and guides users to help get results right the first time.

ICP-MS performance

• 9500 QQQ ICP-MS offers >30% faster acquisition and up to 20x improved sensitivity.

• The platform uses 50% less exhaust flow and 20% less power; opportunity funnel exceeds $60M and is ramping.